Stay updated on ZUMA-2 Study Brexuca Clinical Trial
Sign up to get notified when there's something new on the ZUMA-2 Study Brexuca Clinical Trial page.
Latest updates to the ZUMA-2 Study Brexuca Clinical Trial page
- CheckyesterdayChange DetectedThe latest updates include new definitions and criteria for evaluating treatment responses in mantle cell lymphoma, particularly focusing on the Duration of Response (DOR) and Progression Free Survival (PFS) metrics, while several previous definitions and timeframes have been removed.SummaryDifference46%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference1%
- Check53 days agoChange DetectedThe website has added new features for user interaction while removing extensive options related to participant groups, interventions, and various data fields for downloads.SummaryDifference2%
- Check61 days agoChange DetectedThe website has been updated to version v2.12.2, adding new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference2%
- Check75 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.0%
Stay in the know with updates to ZUMA-2 Study Brexuca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZUMA-2 Study Brexuca Clinical Trial page.